Clozapine and immune function in Parkinson's disease
Treatments studied
Part of Immune system & allergy, Mental health clinical trials.
This trial tests whether clozapine, a medication for psychosis in Parkinson's disease, affects the immune system. It involves regular blood monitoring to help keep patients safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have Parkinson's disease.
- You have psychotic symptoms (like seeing or believing things that aren't real) that need treatment with clozapine.
- Your white blood cell counts are normal before starting the drug.
- You can get blood tests weekly for 18 weeks, then every 4 weeks.
- You do not have a history of serious blood or immune problems, active cancer, epilepsy, or severe organ disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers,” or blood measures, in people with schizophrenia who respond to clozapine. It may help researchers understand who benefits from clozapine and why, by linking test results to symptom changes.
This study tests a new gene therapy (chemogenetics) to see if it is safe and how well it works for people with Parkinson's disease. The treatment involves a one-time infusion of a modified virus into the brain to help control movement symptoms.
This study looks at how antipsychotic medicines affect the immune system in people with psychosis. By taking blood samples before and after starting or changing medication, researchers hope to understand why some people respond better to treatment.
This trial tests whether a regular exercise program can help improve symptoms, thinking, and quality of life for people with schizophrenia who take a specific medication called clozapine.
This study looks at how clozapine and its byproduct (norclozapine) move through your body, and aims to find the best time to test your blood levels. It may help your doctor adjust your dose to reduce side effects.
This study looks at how taking immunosuppressive medicines affects the course of Parkinson's disease. It compares people with Parkinson's who have been on these drugs for over a year to those who have never taken them regularly.
Hear when a new Clozapine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.